Cipla Limited et al v. AstraZeneca AB et al
Cipla Limited and Cipla USA, Inc. |
AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and Zeneca Inc. |
1:2019cv00733 |
April 24, 2019 |
US District Court for the District of Delaware |
Maryellen Noreika |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on July 1, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 24 ORAL ORDER re (24 in 1:19-cv-00438-MN, 23 in 1:19-cv-00733-MN) Status Report - The parties shall file a further status report on or before 7/22/2019. ORDERED by Judge Maryellen Noreika on 7/1/2019. (dlw) |
Filing 23 [SEALED] STATUS REPORT // Letter to the Honorable Maryellen Noreika from Anne Shea Gaza regarding status pursuant to the Court's June 4, 2019 Order by Cipla Limited, Cipla USA, Inc. (Gaza, Anne) Modified on 7/1/2019 (dlw). |
Filing 22 STIPULATION and Proposed Order to File Under Seal by Cipla Limited, Cipla USA, Inc.. (Gaza, Anne) |
SO ORDERED re (22 in 1:19-cv-00733-MN, 23 in 1:19-cv-00438-MN) Stipulation and Proposed Order to File Under Seal. The 7/1/2019 Status Report and all subsequent Status Reports related to the issues discussed during the 6/4/2019 teleconference shall be filed UNDER SEAL. ORDERED by Judge Maryellen Noreika on 7/1/2019. (dlw) |
Minute Entry for proceedings held before Judge Maryellen Noreika - Telephone Conference held on 6/4/2019. The Scheduling Teleconference in this matter will be continued pending the submission of a Status Report as discussed. The parties shall submit a Status Report to the court on or before July 1, 2019. (Court Reporter: Valerie Gunning.) Associated Cases: 1:19-cv-00438-MN, 1:19-cv-00733-MN(asw) |
Filing 21 ORAL ORDER Setting Rule 16 Teleconference: IT IS HEREBY ORDERED that a Rule 16 Scheduling Teleconference is set for 6/4/2019 at 02:00 PM before Judge Maryellen Noreika. Any party wishing to join the call shall do so by individually dialing into 302-573-4545 not earlier than 1:55 PM. ORDERED by Judge Maryellen Noreika on 5/30/2019. (dlw) |
Filing 20 PROPOSED ORDER [Scheduling Order] by Cipla Limited, Cipla USA, Inc.. (Attachments: #1 Letter to The Honorable Maryellen Noreika)(Wilson, Samantha) |
Filing 19 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc. filed by Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc.. (Silver, Daniel) |
Filing 18 ANSWER to #2 Complaint, by Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc..(Silver, Daniel) |
Pro Hac Vice Attorney Robert Stout for Cipla Limited and Cipla USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00438-MN, 1:19-cv-00733-MN(ddp) |
Pro Hac Vice Attorney Anna Q. Han for Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Zeneca Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00438-MN, 1:19-cv-00733-MN(ddp) |
Pro Hac Vice Attorney Einar Stole for Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Zeneca Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00438-MN, 1:19-cv-00733-MN(ddp) |
SO ORDERED re (17 in 1:19-cv-00733-MN, 20 in 1:19-cv-00438-MN) MOTION for Pro Hac Vice Appearance of Attorney Einar Stole and Anna Q. Han filed by Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Zeneca Inc. ORDERED by Judge Maryellen Noreika on 5/10/2019. (dlw) |
Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Einar Stole and Anna Q. Han - filed by Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc.. (Attachments: #1 Certifications for Einar Stole and Anna Q. Han)(Silver, Daniel) |
Filing 16 NOTICE of Appearance by Alexandra M. Joyce on behalf of Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc. (Joyce, Alexandra) |
Filing 15 NOTICE of Appearance by Michael P. Kelly on behalf of Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc. (Kelly, Michael) |
Filing 14 NOTICE of Appearance by Daniel M. Silver on behalf of Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc. (Silver, Daniel) |
SO ORDERED re (19 in 1:19-cv-00438-MN, 13 in 1:19-cv-00733-MN) MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Uma N. Everett and Robert Stout filed by Cipla Limited, Cipla USA, Inc. ORDERED by Judge Maryellen Noreika on 5/6/2019. (dlw) |
Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varughese, Pharm.D., Uma N. Everett and Robert Stout - filed by Cipla Limited, Cipla USA, Inc.. (Wilson, Samantha) |
Filing 12 SUMMONS Returned Executed by Cipla USA, Inc., Cipla Limited. Zeneca Inc. served on 4/25/2019, answer due 5/16/2019. (Wilson, Samantha) |
Filing 11 SUMMONS Returned Executed by Cipla USA, Inc., Cipla Limited. Aktiebolaget Hassle served on 4/25/2019, answer due 5/16/2019. (Wilson, Samantha) |
Filing 10 SUMMONS Returned Executed by Cipla USA, Inc., Cipla Limited. AstraZeneca AB served on 4/25/2019, answer due 5/16/2019. (Wilson, Samantha) |
Filing 9 SUMMONS Returned Executed by Cipla USA, Inc., Cipla Limited. AstraZeneca Pharmaceuticals LP served on 4/25/2019, answer due 5/16/2019. (Wilson, Samantha) |
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
Filing 8 REDACTED VERSION of #2 Complaint, by Cipla Limited, Cipla USA, Inc.. (Attachments: #1 Exhibit A - B)(Wilson, Samantha) |
Filing 7 ORDER granting D.I. #1 MOTION for Leave to File Complaint Under Seal. Signed by Judge Maryellen Noreika on 4/25/2019. (nmg) |
Remark: Case submitted for routine judicial assignment. (nmg) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent InvaGen Pharmaceuticals, Inc., Corporate Parent Cipla Limited, Corporate Parent Cipla (EU Limited) for Cipla USA, Inc. filed by Cipla Limited, Cipla USA, Inc. (nmg) |
Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,428,810. (nmg) |
Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/31/2018. Date of Expiration of Patent: 11/3/2019. (nmg) |
Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
Filing 2 [SEALED] COMPLAINT for Declaratory Judgment of Non-Infringement and Invalidity filed against Aktiebolaget Hassle, AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Zeneca Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number DEX031705.) - filed by Cipla USA, Inc., Cipla Limited. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(nmg) |
Filing 1 MOTION for Leave to File Complaint Under Seal - filed by Cipla Limited, Cipla USA, Inc. (Attachments: #1 Text of Proposed Order)(nmg) |
Remark: Exit copies to Duty Judge (MN). (nmg) |
Summons Issued with Magistrate Consent Notice attached as to Aktiebolaget Hassle on 4/24/2019; AstraZeneca AB on 4/24/2019; AstraZeneca Pharmaceuticals LP on 4/24/2019; Zeneca Inc. on 4/24/2019. (nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.